Cerus Price to Book Ratio 2012-2026 | CERS
Historical price to book ratio values for Cerus (CERS) over the last 10 years. The current price to book ratio for Cerus as of September 14, 2026 is 7.27.
| Cerus Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-15 | 2.50 | 7.12 | |
| 2026-06-30 | 2.92 | $0.35 | 8.32 |
| 2026-03-31 | 1.82 | $0.34 | 5.34 |
| 2025-12-31 | 2.06 | $0.34 | 6.09 |
| 2025-09-30 | 1.59 | $0.32 | 4.91 |
| 2025-06-30 | 1.41 | $0.29 | 4.81 |
| 2025-03-31 | 1.39 | $0.29 | 4.72 |
| 2024-12-31 | 1.54 | $0.31 | 5.03 |
| 2024-09-30 | 1.74 | $0.29 | 5.95 |
| 2024-06-30 | 1.76 | $0.27 | 6.48 |
| 2024-03-31 | 1.89 | $0.27 | 6.96 |
| 2023-12-31 | 2.16 | $0.29 | 7.32 |
| 2023-09-30 | 1.62 | $0.27 | 5.99 |
| 2023-06-30 | 2.46 | $0.29 | 8.60 |
| 2023-03-31 | 2.97 | $0.33 | 9.00 |
| 2022-12-31 | 3.65 | $0.39 | 9.45 |
| 2022-09-30 | 3.60 | $0.42 | 8.62 |
| 2022-06-30 | 5.29 | $0.43 | 12.20 |
| 2022-03-31 | 5.49 | $0.45 | 12.07 |
| 2021-12-31 | 6.81 | $0.49 | 13.81 |
| 2021-09-30 | 6.09 | $0.47 | 12.94 |
| 2021-06-30 | 5.91 | $0.51 | 11.65 |
| 2021-03-31 | 6.01 | $0.54 | 11.08 |
| 2020-12-31 | 6.92 | $0.62 | 11.21 |
| 2020-09-30 | 6.26 | $0.65 | 9.58 |
| 2020-06-30 | 6.60 | $0.69 | 9.57 |
| 2020-03-31 | 4.65 | $0.69 | 6.78 |
| 2019-12-31 | 4.22 | $0.40 | 10.67 |
| 2019-09-30 | 5.16 | $0.43 | 12.04 |
| 2019-06-30 | 5.62 | $0.47 | 11.99 |
| 2019-03-31 | 6.23 | $0.50 | 12.35 |
| 2018-12-31 | 5.07 | $0.62 | 8.21 |
| 2018-09-30 | 7.21 | $0.68 | 10.66 |
| 2018-06-30 | 6.67 | $0.68 | 9.87 |
| 2018-03-31 | 5.48 | $0.66 | 8.36 |
| 2017-12-31 | 3.38 | $0.34 | 10.03 |
| 2017-09-30 | 2.73 | $0.33 | 8.38 |
| 2017-06-30 | 2.51 | $0.36 | 6.97 |
| 2017-03-31 | 4.45 | $0.40 | 11.15 |
| 2016-12-31 | 4.35 | $0.56 | 7.79 |
| 2016-09-30 | 6.21 | $0.70 | 8.89 |
| 2016-06-30 | 6.24 | $0.73 | 8.59 |
| 2016-03-31 | 5.93 | $0.82 | 7.22 |
| 2015-12-31 | 6.32 | $0.96 | 6.61 |
| 2015-09-30 | 4.54 | $0.98 | 4.62 |
| 2015-06-30 | 5.19 | $1.14 | 4.54 |
| 2015-03-31 | 4.17 | $1.15 | 3.62 |
| 2014-12-31 | 6.24 | $0.52 | 12.08 |
| 2014-09-30 | 4.01 | $0.60 | 6.64 |
| 2014-06-30 | 4.15 | $0.60 | 6.95 |
| 2014-03-31 | 4.80 | $0.62 | 7.76 |
| 2013-12-31 | 6.45 | $0.60 | 10.83 |
| 2013-09-30 | 6.72 | $0.51 | 13.28 |
| 2013-06-30 | 4.42 | $0.79 | 5.61 |
| 2013-03-31 | 4.42 | $0.87 | 5.07 |
| 2012-12-31 | 3.16 | $0.34 | 9.30 |
| 2012-09-30 | 3.40 | $0.30 | 11.15 |
| 2012-06-30 | 3.32 | $0.34 | 9.83 |
| 2012-03-31 | 4.02 | $0.35 | 11.33 |
| 2011-12-31 | 2.80 | $0.36 | 7.83 |
| 2011-09-30 | 2.12 | $0.34 | 6.31 |
| 2011-06-30 | 3.00 | $0.28 | 10.80 |
| 2011-03-31 | 2.91 | $0.40 | 7.24 |
| 2010-12-31 | 2.46 | $0.50 | 4.91 |
| 2010-09-30 | 3.84 | $0.31 | 12.48 |
| 2010-06-30 | 3.16 | $0.31 | 10.18 |
| 2010-03-31 | 2.79 | $0.44 | 6.39 |
| 2009-12-31 | 1.99 | $0.55 | 3.59 |
| 2009-09-30 | 2.19 | $0.67 | 3.28 |
| 2009-06-30 | 1.03 | $0.66 | 1.55 |
| 2009-03-31 | 0.68 | $0.84 | 0.81 |
| 2008-12-31 | 0.70 | $1.05 | 0.66 |
| 2008-09-30 | 4.13 | $1.22 | 3.39 |
| 2008-06-30 | 4.09 | $1.47 | 2.78 |
| 2008-03-31 | 5.77 | $1.73 | 3.34 |
| 2007-12-31 | 6.51 | $1.86 | 3.49 |
| 2007-09-30 | 8.73 | $2.16 | 4.04 |
| 2007-06-30 | 6.76 | $2.44 | 2.77 |
| 2007-03-31 | 6.75 | $2.99 | 2.26 |
| 2006-12-31 | 5.86 | $3.18 | 1.84 |
| 2006-09-30 | 5.55 | $2.63 | 2.11 |
| 2006-06-30 | 7.13 | $2.67 | 2.67 |
| 2006-03-31 | 8.56 | $2.82 | 3.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.514B | $0.206B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |